0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
35.47%
Operating income growth of 35.47% while 0819.HK is zero. Bruce Berkowitz would see if this modest edge can become significant.
-97.68%
Negative net income growth while 0819.HK stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-97.61%
Negative EPS growth while 0819.HK is at 3.57%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-97.61%
Negative diluted EPS growth while 0819.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34936.17%
10Y revenue/share CAGR above 1.5x 0819.HK's 635.46%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
39780.80%
5Y revenue/share CAGR above 1.5x 0819.HK's 355.24%. David Dodd would look for consistent product or market expansions fueling outperformance.
11.69%
3Y revenue/share CAGR under 50% of 0819.HK's 93.36%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-62.82%
Negative 10Y OCF/share CAGR while 0819.HK stands at 461.90%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
532.01%
5Y OCF/share CAGR 1.25-1.5x 0819.HK's 441.99%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
-96.14%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
103.33%
Below 50% of 0819.HK's 475.19%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-91.27%
Negative 5Y net income/share CAGR while 0819.HK is 396.61%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
103.23%
3Y net income/share CAGR 50-75% of 0819.HK's 141.76%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
141.40%
3Y equity/share CAGR above 1.5x 0819.HK's 85.92%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-32.98%
Negative near-term dividend growth while 0819.HK invests at 60.23%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
-8.56%
Inventory is declining while 0819.HK stands at 40.93%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.42%
Asset growth well under 50% of 0819.HK's 17.72%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
11.97%
50-75% of 0819.HK's 22.26%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
144.87%
Debt growth far above 0819.HK's 23.37%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.